Diana O Perkins1, Loes Olde Loohuis1, Jenna Barbee1, John Ford1, Clark D Jeffries1, Jean Addington1, Carrie E Bearden1, Kristin S Cadenhead1, Tyrone D Cannon1, Barbara A Cornblatt1, Daniel H Mathalon1, Thomas H McGlashan1, Larry J Seidman1, Ming Tsuang1, Elaine F Walker1, Scott W Woods1. 1. Department of Psychiatry (Perkins, Barbee), Lineberger Bioinformatics Core (Ford), Renaissance Computing Institute (Jeffries), University of North Carolina, Chapel Hill; Center for Neurobehavioral Genetics (Olde Loohuis) and Departments of Psychiatry and Biobehavioral Sciences and Psychology (Bearden), University of California, Los Angeles; Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Alberta, Canada (Addington); Department of Psychiatry (Cadenhead) and Center for Behavioral Genomics, Department of Psychiatry (Tsuang), University of California, San Diego; Department of Psychology, Yale University, New Haven, Conn. (Cannon); Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, N.Y. (Cornblatt); Department of Psychiatry, University of California, San Francisco (Mathalon); Department of Psychiatry, Yale University, New Haven, Conn. (McGlashan, Woods); Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts General Hospital, Boston (Seidman); and Departments of Psychology and Psychiatry, Emory University, Atlanta (Walker).
Abstract
OBJECTIVE: The 2-year risk of psychosis in persons who meet research criteria for a high-risk syndrome is about 15%-25%; improvements in risk prediction accuracy would benefit the development and implementation of preventive interventions. The authors sought to assess polygenic risk score (PRS) prediction of subsequent psychosis in persons at high risk and to determine the impact of adding the PRS to a previously validated psychosis risk calculator. METHODS: Persons meeting research criteria for psychosis high risk (N=764) and unaffected individuals (N=279) were followed for up to 2 years. The PRS was based on the latest schizophrenia and bipolar genome-wide association studies. Variables in the psychosis risk calculator included stressful life events, trauma, disordered thought content, verbal learning, information processing speed, and family history of psychosis. RESULTS: For Europeans, the PRS varied significantly by group and was higher in the psychosis converter group compared with both the nonconverter and unaffected groups, but was similar for the nonconverter group compared with the unaffected group. For non-Europeans, the PRS varied significantly by group; the difference between the converters and nonconverters was not significant, but the PRS was significantly higher in converters than in unaffected individuals, and it did not differ between nonconverters and unaffected individuals. The R2liability (R2 adjusted for the rate of disease risk in the population being studied, here assuming a 2-year psychosis risk between 10% and 30%) for Europeans varied between 9.2% and 12.3% and for non-Europeans between 3.5% and 4.8%. The amount of risk prediction information contributed by the addition of the PRS to the risk calculator was less than severity of disordered thoughts and similar to or greater than for other variables. For Europeans, the PRS was correlated with risk calculator variables of information processing speed and verbal memory. CONCLUSIONS: The PRS discriminates psychosis converters from nonconverters and modestly improves individualized psychosis risk prediction when added to a psychosis risk calculator. The schizophrenia PRS shows promise in enhancing risk prediction in persons at high risk for psychosis, although its potential utility is limited by poor performance in persons of non-European ancestry.
OBJECTIVE: The 2-year risk of psychosis in persons who meet research criteria for a high-risk syndrome is about 15%-25%; improvements in risk prediction accuracy would benefit the development and implementation of preventive interventions. The authors sought to assess polygenic risk score (PRS) prediction of subsequent psychosis in persons at high risk and to determine the impact of adding the PRS to a previously validated psychosis risk calculator. METHODS: Persons meeting research criteria for psychosis high risk (N=764) and unaffected individuals (N=279) were followed for up to 2 years. The PRS was based on the latest schizophrenia and bipolar genome-wide association studies. Variables in the psychosis risk calculator included stressful life events, trauma, disordered thought content, verbal learning, information processing speed, and family history of psychosis. RESULTS: For Europeans, the PRS varied significantly by group and was higher in the psychosis converter group compared with both the nonconverter and unaffected groups, but was similar for the nonconverter group compared with the unaffected group. For non-Europeans, the PRS varied significantly by group; the difference between the converters and nonconverters was not significant, but the PRS was significantly higher in converters than in unaffected individuals, and it did not differ between nonconverters and unaffected individuals. The R2liability (R2 adjusted for the rate of disease risk in the population being studied, here assuming a 2-year psychosis risk between 10% and 30%) for Europeans varied between 9.2% and 12.3% and for non-Europeans between 3.5% and 4.8%. The amount of risk prediction information contributed by the addition of the PRS to the risk calculator was less than severity of disordered thoughts and similar to or greater than for other variables. For Europeans, the PRS was correlated with risk calculator variables of information processing speed and verbal memory. CONCLUSIONS: The PRS discriminates psychosis converters from nonconverters and modestly improves individualized psychosis risk prediction when added to a psychosis risk calculator. The schizophrenia PRS shows promise in enhancing risk prediction in persons at high risk for psychosis, although its potential utility is limited by poor performance in persons of non-European ancestry.
Authors: S-H Wang; P-C Hsiao; L-L Yeh; C-M Liu; C-C Liu; T-J Hwang; M H Hsieh; Y-L Chien; Y-T Lin; S D Chandler; S V Faraone; N Laird; B Neale; S A McCarroll; S J Glatt; M T Tsuang; H-G Hwu; W J Chen Journal: Genes Brain Behav Date: 2017-08-08 Impact factor: 3.449
Authors: Adam J Ciarleglio; Gary Brucato; Michael D Masucci; Rebecca Altschuler; Tiziano Colibazzi; Cheryl M Corcoran; Francesca M Crump; Guillermo Horga; Eugénie Lehembre-Shiah; Wei Leong; Scott A Schobel; Melanie M Wall; Lawrence H Yang; Jeffrey A Lieberman; Ragy R Girgis Journal: Psychol Med Date: 2018-06-28 Impact factor: 7.723
Authors: P Fusar-Poli; M Tantardini; S De Simone; V Ramella-Cravaro; D Oliver; J Kingdon; M Kotlicka-Antczak; L Valmaggia; J Lee; M J Millan; S Galderisi; U Balottin; V Ricca; P McGuire Journal: Eur Psychiatry Date: 2016-12-16 Impact factor: 5.361
Authors: Ricardo E Carrión; Barbara A Cornblatt; Cynthia Z Burton; Ivy F Tso; Andrea M Auther; Steven Adelsheim; Roderick Calkins; Cameron S Carter; Tara Niendam; Tamara G Sale; Stephan F Taylor; William R McFarlane Journal: Am J Psychiatry Date: 2016-07-01 Impact factor: 18.112
Authors: Barnaby Nelson; Hok Pan Yuen; Stephen J Wood; Ashleigh Lin; Daniela Spiliotacopoulos; Annie Bruxner; Christina Broussard; Magenta Simmons; Debra L Foley; Warrick J Brewer; Shona M Francey; G Paul Amminger; Andrew Thompson; Patrick D McGorry; Alison R Yung Journal: JAMA Psychiatry Date: 2013-08 Impact factor: 21.596
Authors: Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon Journal: Schizophr Bull Date: 2007-04-17 Impact factor: 9.306
Authors: Evangelos Vassos; Marta Di Forti; Jonathan Coleman; Conrad Iyegbe; Diana Prata; Jack Euesden; Paul O'Reilly; Charles Curtis; Anna Kolliakou; Hamel Patel; Stephen Newhouse; Matthew Traylor; Olesya Ajnakina; Valeria Mondelli; Tiago Reis Marques; Poonam Gardner-Sood; Katherine J Aitchison; John Powell; Zerrin Atakan; Kathryn E Greenwood; Shubulade Smith; Khalida Ismail; Carmine Pariante; Fiona Gaughran; Paola Dazzan; Hugh S Markus; Anthony S David; Cathryn M Lewis; Robin M Murray; Gerome Breen Journal: Biol Psychiatry Date: 2016-08-06 Impact factor: 13.382
Authors: Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff Journal: Schizophr Res Date: 2020-06-01 Impact factor: 4.939
Authors: Nikolaos Koutsouleris; Michelle Worthington; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Rachele Sanfelici; Paolo Fusar-Poli; Marlene Rosen; Stephan Ruhrmann; Alan Anticevic; Jean Addington; Diana O Perkins; Carrie E Bearden; Barbara A Cornblatt; Kristin S Cadenhead; Daniel H Mathalon; Thomas McGlashan; Larry Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Peter Falkai; Rebekka Lencer; Alessandro Bertolino; Joseph Kambeitz; Frauke Schultze-Lutter; Eva Meisenzahl; Raimo K R Salokangas; Jarmo Hietala; Paolo Brambilla; Rachel Upthegrove; Stefan Borgwardt; Stephen Wood; Raquel E Gur; Philip McGuire; Tyrone D Cannon Journal: Biol Psychiatry Date: 2021-07-06 Impact factor: 13.382
Authors: Isotta Landi; Deepak A Kaji; Liam Cotter; Tielman Van Vleck; Gillian Belbin; Michael Preuss; Ruth J F Loos; Eimear Kenny; Benjamin S Glicksberg; Noam D Beckmann; Paul O'Reilly; Eric E Schadt; Eric D Achtyes; Peter F Buckley; Douglas Lehrer; Dolores P Malaspina; Steven A McCarroll; Mark H Rapaport; Ayman H Fanous; Michele T Pato; Carlos N Pato; Tim B Bigdeli; Girish N Nadkarni; Alexander W Charney Journal: Nat Med Date: 2021-09-06 Impact factor: 53.440
Authors: Katrina Aberizk; Meghan A Collins; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Tyrone D Cannon; Elaine F Walker Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2021-04-28
Authors: Guiyan Ni; Jian Zeng; Joana A Revez; Ying Wang; Zhili Zheng; Tian Ge; Restuadi Restuadi; Jacqueline Kiewa; Dale R Nyholt; Jonathan R I Coleman; Jordan W Smoller; Jian Yang; Peter M Visscher; Naomi R Wray Journal: Biol Psychiatry Date: 2021-05-04 Impact factor: 12.810
Authors: Nicole R Karcher; Sarah E Paul; Emma C Johnson; Alexander S Hatoum; David A A Baranger; Arpana Agrawal; Wesley K Thompson; Deanna M Barch; Ryan Bogdan Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2021-07-13